DermTech, Inc. (DMTKQ) vs ProPhase Labs, Inc. (PRPH)
DermTech, Inc. and ProPhase Labs, Inc. are both Diagnostics & Research companies. DermTech, Inc. is the larger, with a market value of $3.3M against $1.2M — 2.8× the size. DermTech, Inc. grew revenue faster over the last twelve months: 9.71% against −43.5%. DermTech, Inc. has the higher net margin (−572.2% vs −717.4%) and the lower return on invested capital (−5,493.5% vs −387.3%). Across the 16 metrics below, DermTech, Inc. leads on 8 and ProPhase Labs, Inc. on 8.
Valuation
Profitability
| Metric | DMTKQ | PRPH | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 8.51% | 16.38% | 50.89% |
| Operating margin | (588.62%) | (498.73%) | (8.57%) |
| Net margin | (572.19%) | (717.43%) | (6.37%) |
| Free cash flow margin | (460.10%) | (175.22%) | 0.00% |
| Return on equity | (121.75%) | (543.95%) | (2.92%) |
| Return on assets | (64.00%) | (45.53%) | (6.71%) |
| Return on invested capital | (5,493.45%) | (387.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack